CA2258679C - Solution solide d'un agent antifongique avec biodisponibilite amelioree - Google Patents
Solution solide d'un agent antifongique avec biodisponibilite amelioree Download PDFInfo
- Publication number
- CA2258679C CA2258679C CA002258679A CA2258679A CA2258679C CA 2258679 C CA2258679 C CA 2258679C CA 002258679 A CA002258679 A CA 002258679A CA 2258679 A CA2258679 A CA 2258679A CA 2258679 C CA2258679 C CA 2258679C
- Authority
- CA
- Canada
- Prior art keywords
- solid solution
- compound
- composition
- povidone
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67270696A | 1996-06-28 | 1996-06-28 | |
| US08/672,706 | 1996-06-28 | ||
| PCT/US1997/010120 WO1998000113A1 (fr) | 1996-06-28 | 1997-06-25 | Solution solide d'un agent antifongique avec biodisponibilite amelioree |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2258679A1 CA2258679A1 (fr) | 1998-01-08 |
| CA2258679C true CA2258679C (fr) | 2007-05-29 |
Family
ID=38151061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002258679A Expired - Fee Related CA2258679C (fr) | 1996-06-28 | 1997-06-25 | Solution solide d'un agent antifongique avec biodisponibilite amelioree |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2258679C (fr) |
-
1997
- 1997-06-25 CA CA002258679A patent/CA2258679C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2258679A1 (fr) | 1998-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5972381A (en) | Solid solution of an antifungal agent with enhanced bioavailability | |
| EP0954288B1 (fr) | Solution solide d'un agent antifongique avec biodisponibilite amelioree | |
| RU2351316C2 (ru) | Лекарственные формы с замедленным высвобождением зипразидона | |
| KR100904602B1 (ko) | 염기성 약물 또는 그의 염을 함유하는 매트릭스형 서방성 제제 및 그의 제조 방법 | |
| KR19990044653A (ko) | 다리페나신을 함유하는 약학 제제 | |
| EP1233768A1 (fr) | Methane-sulfonate de carvedilol | |
| EP1039909A1 (fr) | Procede et composition d'une preparation orale d'itraconazole | |
| EP1266657A1 (fr) | Compositions pharmaceutiques d'hydrochlorure de bupropion, stabilisées par la cyclodextrine | |
| EP0136103A2 (fr) | Formulations à action prolongée du chlorohydrate d'amosulalol | |
| US6632455B2 (en) | Molecular dispersion composition with enhanced bioavailability | |
| JP2010059212A (ja) | バイオアベイラビリティーを高めた分子分散組成物 | |
| JP3110794B2 (ja) | １，４−ジヒドロピリジン誘導体を含有する製剤 | |
| WO2004006904A1 (fr) | Formes posologiques a liberation controlee administrees par voie orale contenant de l'acetaminophene | |
| KR100267525B1 (ko) | 시타라빈 옥포스페이트 경질 캡슐제 | |
| CA2258679C (fr) | Solution solide d'un agent antifongique avec biodisponibilite amelioree | |
| CA2253769C (fr) | Composes pharmaceutiques a base de fenofibrate | |
| US20060030581A1 (en) | Mannitol formulation for integrin receptor antagonist | |
| EP0487335A1 (fr) | Formes pharmaceutiques d'administration de dihydropyridines | |
| KR100568428B1 (ko) | 용해도가 개선된 카르베딜롤 제제 | |
| JPH0759521B2 (ja) | ゲル層形成型徐放性製剤 | |
| KR100546047B1 (ko) | 디히드로피리딘계 화합물의 서방출성 제제 및 그 제조방법 | |
| JP2676305B2 (ja) | シタラビンオクホスファート硬カプセル剤 | |
| WO2021239893A1 (fr) | Dispersion solide amorphe d'acalabrutinib | |
| WO2004024138A1 (fr) | Preparation solide contenant du sulfosuccinate de dioctyl sodium | |
| JPH09263536A (ja) | テルフェナジンを含有する医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |